Michael R Megna Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Michael R Megna is CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 38,011 shares of KNSA, which is worth approximately $1.4 Million. The most recent transaction as insider was on Sep 03, 2025, when has been sold 11,000 shares (Class A Ordinary Share) at a price of $34.84 per share, resulting in proceeds of $383,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38K

16.79% 3M change

43.79% 12M change

Total Value Held $1.4 Million

Michael R Megna Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2025	SELL Open market or private sale	$383,240 $34.84 p/Share	11,000 Reduced 22.44%	38,011 Class A Ordinary Share
Sep 03 2025	BUY Exercise of conversion of derivative security	$197,120 $17.92 p/Share	11,000 Added 18.33%	49,011 Class A Ordinary Share
Sep 02 2025	SELL Payment of exercise price or tax liability	$12,855 $34.28 p/Share	375 Reduced 0.98%	38,011 Class A Ordinary Share
Sep 02 2025	BUY Exercise of conversion of derivative security	-	774 Added 1.98%	38,386 Class A Ordinary Share
Sep 01 2025	SELL Payment of exercise price or tax liability	$143,404 $33.49 p/Share	4,282 Reduced 10.22%	37,612 Class A Ordinary Share
Sep 01 2025	BUY Exercise of conversion of derivative security	-	8,853 Added 17.45%	41,894 Class A Ordinary Share
Aug 04 2025	SELL Open market or private sale	$549,950 $32.35 p/Share	17,000 Reduced 33.97%	33,041 Class A Ordinary Share
Aug 04 2025	BUY Exercise of conversion of derivative security	$263,840 $15.52 p/Share	17,000 Added 25.36%	50,041 Class A Ordinary Share
Jul 15 2025	BUY Grant, award, or other acquisition	$7,736 $15.63 p/Share	495 Added 1.48%	33,041 Class A Ordinary Share
Jun 03 2025	SELL Open market or private sale	$437,316 $28.75 p/Share	15,211 Reduced 31.85%	32,546 Class A Ordinary Share
Jun 03 2025	BUY Exercise of conversion of derivative security	$235,770 $15.5 p/Share	15,211 Added 24.16%	47,757 Class A Ordinary Share
May 07 2025	SELL Open market or private sale	$470,998 $26.69 p/Share	17,647 Reduced 35.16%	32,546 Class A Ordinary Share
May 07 2025	BUY Exercise of conversion of derivative security	$213,528 $12.1 p/Share	17,647 Added 26.01%	50,193 Class A Ordinary Share
Apr 07 2025	SELL Payment of exercise price or tax liability	$33,786 $20.28 p/Share	1,666 Reduced 4.87%	32,546 Class A Ordinary Share
Apr 07 2025	BUY Exercise of conversion of derivative security	-	3,933 Added 10.31%	34,212 Class A Ordinary Share
Apr 01 2025	SELL Payment of exercise price or tax liability	$45,368 $21.77 p/Share	2,084 Reduced 6.44%	30,279 Class A Ordinary Share
Apr 01 2025	BUY Exercise of conversion of derivative security	-	4,920 Added 13.2%	32,363 Class A Ordinary Share
Mar 16 2025	SELL Payment of exercise price or tax liability	$7,416 $22.61 p/Share	328 Reduced 1.18%	27,443 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	774 Added 2.71%	27,771 Class A Ordinary Share
Mar 12 2025	SELL Open market or private sale	$203,194 $22.45 p/Share	9,051 Reduced 25.44%	26,528 Class A Ordinary Share
Mar 12 2025	BUY Exercise of conversion of derivative security	$100,466 $11.1 p/Share	9,051 Added 20.28%	35,579 Class A Ordinary Share
Jan 15 2025	BUY Grant, award, or other acquisition	$7,504 $16.0 p/Share	469 Added 1.71%	26,997 Class A Ordinary Share
Nov 29 2024	SELL Open market or private sale	$202 $22.45 p/Share	9 Reduced 0.03%	26,528 Class A Ordinary Share
Nov 29 2024	BUY Exercise of conversion of derivative security	$99 $11.1 p/Share	9 Added 0.03%	26,537 Class A Ordinary Share
Nov 27 2024	SELL Open market or private sale	$193,900 $22.45 p/Share	8,637 Reduced 24.56%	26,528 Class A Ordinary Share

MRM

Michael R Megna

CHIEF ACCOUNTING OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account